We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-3.98%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.61B
AUM Growth
-$176M
Cap. Flow
-$7.57M
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.38%
Holding
278
New
8
Increased
76
Reduced
97
Closed
17

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$43.2M
2
TECK icon
Teck Resources
TECK
+$40.4M
3
SMCI icon
Super Micro Computer
SMCI
+$24.4M
4
BN icon
Brookfield
BN
+$19.2M
5
HCA icon
HCA Healthcare
HCA
+$17M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$47M
2
CCK icon
Crown Holdings
CCK
+$38.1M
3
AEM icon
Agnico Eagle Mines
AEM
+$32M
4
SLG icon
SL Green Realty
SLG
+$21.7M
5
KMX icon
CarMax
KMX
+$19.1M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 15.85%
3 Healthcare 13.12%
4 Consumer Discretionary 10.92%
5 Materials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYA
201
DELISTED
Simplify Tail Risk Strategy ETF
CYA
$483K 0.02%
1,050
– –
YTEN
202
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$482K 0.02%
6,718
-4
-0.1% -$270
SJR
203
DELISTED
Shaw Communications Inc.
SJR
$471K 0.02%
19,357
– –
CVS icon
204
CVS Health
CVS
$136B
$466K 0.02%
4,890
+500
+11% +$49.5K
ED icon
205
Consolidated Edison
ED
$41.4B
$455K 0.02%
5,300
– –
NVDA icon
206
NVIDIA
NVDA
$4.76T
$434K 0.02%
35,720
– –
GXO icon
207
GXO Logistics
GXO
$6.09B
$433K 0.02%
12,351
-335
-3% -$14.8K
WFC icon
208
Wells Fargo
WFC
$265B
$428K 0.02%
10,650
– –
EL icon
209
Estee Lauder
EL
$29.5B
$405K 0.02%
1,875
– –
SYK icon
210
Stryker
SYK
$129B
$404K 0.02%
1,996
– –
VGIT icon
211
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$395K 0.02%
6,774
-81
-1% -$4.91K
ISRG icon
212
Intuitive Surgical
ISRG
$128B
$389K 0.01%
2,075
– –
TGI
213
DELISTED
Triumph Group
TGI
$387K 0.01%
45,043
– –
GIS icon
214
General Mills
GIS
$19.5B
$383K 0.01%
4,995
– –
HES
215
DELISTED
Hess
HES
$382K 0.01%
3,504
– –
PLTR icon
216
Palantir
PLTR
$310B
$379K 0.01%
46,562
– –
TMHC icon
217
Taylor Morrison
TMHC
$367K 0.01%
15,733
– –
NVS icon
218
Novartis
NVS
$298B
$358K 0.01%
4,706
-390
-8% -$32.3K
NOC icon
219
Northrop Grumman
NOC
$77.8B
$329K 0.01%
+700
New +$334K
SLG icon
220
SL Green Realty
SLG
$3.85B
$321K 0.01%
7,986
-466,618
-98% -$21.7M
CNQ icon
221
Canadian Natural Resources
CNQ
$94B
$312K 0.01%
+13,400
New +$347K
REYN icon
222
Reynolds Consumer Products
REYN
$5.41B
$312K 0.01%
12,000
– –
GILD icon
223
Gilead Sciences
GILD
$164B
$310K 0.01%
5,025
-950
-16% -$59.9K
AON icon
224
Aon
AON
$78.8B
$298K 0.01%
1,112
-400
-26% -$113K
NKE icon
225
Nike
NKE
$62.3B
$297K 0.01%
3,575
+40
+1% +$4.31K
7 8
9
10 11

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Cannell & Co held 278 positions worth $2.61B, down 6.3% from $2.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cannell & Co's Q3 2022 filing shows 8 new, 76 increased, 97 reduced and 17 closed positions. Its largest new stake was EQT Corp: 996,050 shares worth $40.6M. The largest sale was AstraZeneca, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Cannell & Co's largest Q3 2022 buy was EQT Corp: 996,050 shares worth $40.6M.
  • Cannell & Co added most to Teck Resources in Q3 2022, an estimated $40.4M increase.
  • Cannell & Co's biggest Q3 2022 reduction was Crown Holdings, cutting an estimated $38.1M.
  • Cannell & Co fully exited AstraZeneca in Q3 2022, selling an estimated $47M.
  • Cannell & Co's ten largest holdings make up 29% of its $2.61B portfolio in Q3 2022.
  • Cannell & Co opened 8 new positions and closed 17 in Q3 2022.
  • Cannell & Co's portfolio value fell 6.3% quarter-over-quarter to $2.61B.

Based on Cannell & Co's 13F filing for Q3 2022, filed 2 Nov 2022.